Skip to main content
. 2023 Apr 18;7(4):273–285. doi: 10.4049/immunohorizons.2300003

Table II. In vitro potency of ustekinumab and guselkumab on cytokine production.

IC50 (nM)
Cytokine GUS UST Increased Potency of GUSa
IL-17A 0.10 0.38 3.8
IL-17F 0.11 0.49 4.5
IL-22 0.09 0.40 4.4
a

UST IC50:GUS IC50.

GUS, guselkumab; UST, ustekinumab.